Automated Cell Culture System Market Regional Analysis:
North America industry is predicted to dominate majority revenue share of 41% by 2035, attributed to rising investment in research and development in the region. The growth of the market is attributed to rising investment in research and development in the region. The National Cancer Institute (NIC) published statistics showing that the NCI budget to make funding for research for cancer reached USD 6440.4 million in 2020. Additionally, the higher prevalence of chronic diseases and the presence of major key players in the region is further expected to propel the growth of the market over the forecast period. Furthermore, the Europe region is also estimated to provide a lucrative opportunity for the market to grow exponentially.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of automated cell culture system is evaluated at USD 17.88 Billion.
The global automated cell culture system market size was worth over USD 16.58 Billion in 2025 and is poised to grow at a CAGR of around 8.7%, reaching USD 38.18 Billion revenue by 2035.
North America automated cell culture system market will dominate over 41% share by 2035, driven by rising investment in R&D, high prevalence of chronic diseases, and presence of key market players.
Key players in the market include Hitachi Power Solutions Co, Ltd., Lonza Group Ltd., Thermo Fisher Scientific Company, Cell Culture Company, LLC, Sartorius AG, Becton, Dickinson and Company, Hamilton Company, Merck Group, F. Hoffmann-La Roche AG, Novartis AG.
